A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

NCT02150499 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: levalbuterol tartrate HFA inhalation aerosol
DRUG: placebo

Sponsor

Sumitomo Pharma America, Inc.